Nrf2 downregulation inhibited melanoma cell proliferation, migration, and invasion [148,149], induced apoptosis [148], enhanced sensitivity toward oxidative stress [149] and ionizing radiation [148], and reverted chemoresistance to cisplatin, dacarbazine [150], and TMZ [151]. The gene discussed is NFE2L2; the disease is melanoma.